(Reuters) – A US judge on Friday allowed Purdue Pharma to immediately question her refusal to grant legal protection to Sackler family members who own the OxyContin manufacturer, and which was an important part of its bankruptcy reorganization plan. District Judge Colleen McMahon's ruling means Purdue will have another chance to maintain a $ 4.5 billion settlement on opioid disputes at the heart of the company's plan. She gave Purdue until Jan. 17 to file the appeal to the New York-based 2nd U.S. Pat. Circuit Court of Appeals
Judge McMahon reversed a bankruptcy judge's decision approving the deal in December. The settlement provides for so-called releases from non-debtors that protect Sacklers from future opioid-related lawsuits. $ 4.5 billion to the settlement in exchange for the releases. According to Purdue's reorganization plan, settlement funds would be targeted at opioid reduction programs.